Comprehensive mechanistic analysis of hits from high-throughput and docking screens against β-lactamase

被引:137
作者
Babaoglu, Kerim [2 ]
Simeonov, Anton [1 ]
Lrwin, John J. [2 ]
Nelson, Michael E. [1 ]
Feng, Brian [2 ]
Thomas, Craig J. [1 ]
Cancian, Laura [4 ]
Costi, M. Paola [4 ]
Maltby, David A. [3 ]
Jadhav, Ajit [1 ]
Inglese, James [1 ]
Austin, Christopher P. [1 ]
Shoichet, Brian K. [2 ]
机构
[1] NHGRI, Chem Genom Ctr, NIH, Bethesda, MD 20892 USA
[2] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
[3] Univ Calif San Francisco, Dept Pharmaceut Chem, Mass Spect Facil, San Francisco, CA 94143 USA
[4] Univ Modena & Reggio Emilia, Dipartimento Sci Farmaceut, I-41100 Modena, Italy
关键词
D O I
10.1021/jm701500e
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
High-throughput screening (HTS) is widely used in drug discovery. Especially for screens of unbiased libraries, false positives can dominate "hit lists"; their origins are much debated. Here we determine the mechanism of every active hit from a screen of 70,563 unbiased molecules against P-lactamase using quantitative HTS (qHTS). Of the 1274 initial inhibitors, 95% were detergent- sensitive and were classified as aggregators. Among the 70 remaining were 25 potent, covalent-acting beta-lactams. Mass spectra, counter-screens, and crystallography identified 12 as promiscuous covalent inhibitors. The remaining 33 were either aggregators or irreproducible. No specific reversible inhibitors were found. We turned to molecular docking to prioritize molecules from the same library for testing at higher concentrations. Of 16 tested, 2 were modest inhibitors. Subsequent X-ray structures corresponded to the docking prediction. Analog synthesis improved affinity to 8 mu M. These results suggest that it may be the physical behavior of organic molecules, not their reactivity, that accounts for most screening artifacts. Structure-based methods may prioritize weak-but-novel chemotypes in unbiased library screens.
引用
收藏
页码:2502 / 2511
页数:10
相关论文
共 49 条
  • [21] Navigating chemical space for biology and medicine
    Lipinski C.
    Hopkins A.
    [J]. Nature, 2004, 432 (7019) : 855 - 861
  • [22] Hierarchical docking of databases of multiple ligand conformations
    Lorber, DM
    Shoichet, BK
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (08) : 739 - 749
  • [23] Critical review of the role of HTS in drug discovery
    Macarron, R
    [J]. DRUG DISCOVERY TODAY, 2006, 11 (7-8) : 277 - 279
  • [24] Likelihood-enhanced fast translation functions
    McCoy, AJ
    Grosse-Kunstleve, RW
    Storoni, LC
    Read, RJ
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2005, 61 : 458 - 464
  • [25] A specific mechanism of nonspecific inhibition
    McGovern, SL
    Helfand, BT
    Feng, B
    Shoichet, BK
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (20) : 4265 - 4272
  • [26] A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
    McGovern, SL
    Caselli, E
    Grigorieff, N
    Shoichet, BK
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (08) : 1712 - 1722
  • [27] Nanomolar inhibitors of AmpC β-lactamase
    Morandi, F
    Caselli, E
    Morandi, S
    Focia, PJ
    Blázquez, J
    Shoichet, BK
    Prati, F
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (03) : 685 - 695
  • [28] Refinement of macromolecular structures by the maximum-likelihood method
    Murshudov, GN
    Vagin, AA
    Dodson, EJ
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 1997, 53 : 240 - 255
  • [29] Current trends in lead discovery: Are we looking for the appropriate properties?
    Oprea, TI
    [J]. MOLECULAR DIVERSITY, 2000, 5 (04) : 199 - 208
  • [30] Lead-like, drug-like or "pub-like": how different are they?
    Oprea, Tudor I.
    Allu, Tharun Kumar
    Fara, Dan C.
    Rad, Ramona F.
    Ostopovici, Lili
    Bologa, Cristian G.
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2007, 21 (1-3) : 113 - 119